These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Zarandi M; Cai R; Kovacs M; Popovics P; Szalontay L; Cui T; Sha W; Jaszberenyi M; Varga J; Zhang X; Block NL; Rick FG; Halmos G; Schally AV Peptides; 2017 Mar; 89():60-70. PubMed ID: 28130121 [TBL] [Abstract][Full Text] [Related]
3. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949 [TBL] [Abstract][Full Text] [Related]
4. Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor. Hassan HA; Hsiung HM; Zhang XY; Smith DP; Smiley DL; Heiman ML Peptides; 1995; 16(8):1469-73. PubMed ID: 8745060 [TBL] [Abstract][Full Text] [Related]
5. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity. Massoud AF; Hindmarsh PC; Matthews DR; Brook CG Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732 [TBL] [Abstract][Full Text] [Related]
6. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186 [TBL] [Abstract][Full Text] [Related]
7. Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide. Heiat M; Ranjbar R; Latifi AM; Rasaee MJ Peptides; 2016 Aug; 82():101-108. PubMed ID: 27298205 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of growth hormone-releasing hormone (GHRH) with a polyclonal antibody against synthetic GHRH(1-29)-Gly4-Cys-NH2: method and clinical studies. Zhang CY; Yamasaki R; Mitsuhashi S; Takahashi H; Bando H; Saito S Clin Chim Acta; 1991 Oct; 202(3):243-54. PubMed ID: 1687674 [TBL] [Abstract][Full Text] [Related]
9. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366 [TBL] [Abstract][Full Text] [Related]
10. Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Massoud AF; Hindmarsh PC; Brook CG Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393 [TBL] [Abstract][Full Text] [Related]
12. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Halmos G; Schally AV; Varga JL; Plonowski A; Rekasi Z; Czompoly T Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10555-60. PubMed ID: 10962030 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer. Pópulo H; Nunes B; Sampaio C; Batista R; Pinto MT; Gaspar TB; Miranda-Alves L; Cai RZ; Zhang XY; Schally AV; Sobrinho-Simões M; Soares P Horm Cancer; 2017 Dec; 8(5-6):314-324. PubMed ID: 28924876 [TBL] [Abstract][Full Text] [Related]
14. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Doga M; Bonadonna S; Burattin A; Giustina A Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Barron JL; Coy DH; Millar RP Peptides; 1985; 6(3):575-7. PubMed ID: 2866496 [TBL] [Abstract][Full Text] [Related]
17. Identification of the endogenous ligands for chicken growth hormone-releasing hormone (GHRH) receptor: evidence for a separate gene encoding GHRH in submammalian vertebrates. Wang Y; Li J; Wang CY; Kwok AH; Leung FC Endocrinology; 2007 May; 148(5):2405-16. PubMed ID: 17272401 [TBL] [Abstract][Full Text] [Related]
18. Dynamic properties of the growth hormone releasing hormone receptor (GHRHR) and molecular determinants of GHRH binding. Matsoukas MT; Spyroulias GA Mol Biosyst; 2017 Jun; 13(7):1313-1322. PubMed ID: 28561845 [TBL] [Abstract][Full Text] [Related]
19. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation. Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774 [TBL] [Abstract][Full Text] [Related]
20. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]